SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emilie Camberlein, Emmanuelle Abgueguen, Nadia Fatih, François Canonne-Hergaux, Patricia Leroyer, Bruno Turlin, Martine Ropert, Pierre Brissot, Olivier Loréal, Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 3, 339

    CrossRef

  2. 2
    Hui-Ying Rao, Lai Wei, Jiang-Hua Wang, Ran Fei, Dong Jiang, Quan Zhang, Hong-Song Chen, Xu Cong, Inhibitory effect of human interferon-beta-1a on activated rat and human hepatic stellate cells, Journal of Gastroenterology and Hepatology, 2010, 25, 11
  3. 3
    Massimo Franchini, Giovanni Targher, Franco Capra, Martina Montagnana, Giuseppe Lippi, The effect of iron depletion on chronic hepatitis C virus infection, Hepatology International, 2008, 2, 3, 335

    CrossRef

  4. 4
    Krystyna Pawlak, Michal Mysliwiec, Dariusz Pawlak, Chronic viral hepatitis and iron affect the plasma levels of LIGHT—a new member of the TNF superfamily in uraemic haemodialyzed patients, Cytokine, 2007, 39, 3, 201

    CrossRef

  5. 5
    Yoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, Naohisa Yoshida, Kyoko Sakai, Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis C, Hepatology Research, 2007, 37, 4
  6. 6
    Naoki Fujita, Ryosuke Sugimoto, Naohito Urawa, Hideaki Tanaka, Masayoshi Konishi, Yoshinao Kobayashi, Motoh Iwasa, Shozo Watanabe, Masahiko Kaito, Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C, Journal of Gastroenterology, 2007, 42, 4, 326

    CrossRef

  7. 7
    Naoki Fujita, Yoshiyuki Takei, Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C, Journal of Gastroenterology, 2007, 42, 11, 923

    CrossRef

  8. 8
    Hitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, Junichi Yoshii, Yasuhide Ikenaka, Koji Yanase, Tadashi Namisaki, Mitsuteru Kitade, Masaharu Yamazaki, Hirohisa Tsujinoue, Hiroshi Fukui, Combination of interferon-β and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development, Liver International, 2005, 25, 1
  9. 9
    Seong Soo Joo, Do Ik Lee, The potential anti-HBV effect of amantadine in combination with ursodeoxycholic acid and biphenyl dimethyl dicarboxylate in HepG2 2.2.15 cells, Archives of Pharmacal Research, 2005, 28, 4, 451

    CrossRef

  10. 10
    Georges Carrera, Jose Luis Paternain, Nicolas Carrere, Jaume Folch, Monique Courtade-Saidi, Claudine Orfila, Jean Pierre Vinel, Laurent Alric, Bernard Pipy, Hepatic metallothionein in patients with chronic hepatitis C. Relationship with severity of liver disease and response to treatment, The American Journal of Gastroenterology, 2003, 98, 5, 1142

    CrossRef

  11. 11
    Hiroshi Yotsuyanagi, Yuzo Miyakawa, Shiro Iino, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  12. 12
    Paul Angulo, Use of ursodeoxycholic acid in patients with liver disease, Current Gastroenterology Reports, 2002, 4, 1, 37

    CrossRef

  13. 13
    Norah A. Terrault, Chronic hepatitis B, Current Treatment Options in Gastroenterology, 2001, 4, 6, 493

    CrossRef

  14. 14
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Disease-a-Month, 2001, 47, 12, 610

    CrossRef

  15. 15
    Herbert L. Bonkovsky, Savant Mehta, Hepatitis C: A review and update, Journal of the American Academy of Dermatology, 2001, 44, 2, 159

    CrossRef

  16. 16
    John G. McHutchison, Ryan Ponnudurai, David L. Bylund, Ariel Anguiano, Paul J. Pockros, Tony Mondala, Linda B. Wilkes, Prednisone Withdrawal Followed by Interferon Alpha for Treatment of Chronic Hepatitis C Infection, Journal of Clinical Gastroenterology, 2001, 32, 2, 133

    CrossRef

  17. 17
    Ke-Qin Hu, John M. Vierling, Allan G. Redeker, Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1, 1

    CrossRef

  18. 18
    Ke-Qin Hu, John M. Vierling, Allan G. Redeker, Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1
  19. 19
    Ryoji Hatano, Masaaki Ebara, Hiroyuki Fukuda, Masaharu Yoshikawa, Nobuyuki Sugiura, Fukuo Kondo, Masae Yukawa, Hiromitsu Saisho, Accumulation of copper in the liver and hepatic injury in chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2000, 15, 7
  20. 20
    Steedman A. Sarbah, Zobair M. Younossi, Hepatitis C, Journal of Clinical Gastroenterology, 2000, 30, 2, 125

    CrossRef

  21. 21
    Robert J. Fontana, Jonathan Israel, Paula LeClair, Barbara F. Banner, Kristina Tortorelli, Norman Grace, Robert A. Levine, Gale Fiarman, Michael Thiim, Anthony S. Tavill, Herbert L. Bonkovsky, Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial, Hepatology, 2000, 31, 3
  22. 22
    Magda Guilera, Xavier Forns, Xavier Torras, Jaime Enríquez, Susana Coll, Ricard Solà, Rosa Morillas, Ramón Planas, Sergi Ampurdanès, Marta Soler, Josep Costa, Juan C Sáiz, José M Sánchez-Tapias, Juan Rodés, Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C, Journal of Hepatology, 2000, 33, 1, 135

    CrossRef

  23. 23
    Mei-Hwei Chang, Treatment of chronic hepatitis C virus infection in children, Best Practice & Research Clinical Gastroenterology, 2000, 14, 2, 341

    CrossRef

  24. 24
    Sk Sarin, What should we advise about adjunctive therapies, including herbal medicines, for hepatitis C?, Journal of Gastroenterology and Hepatology, 2000, 15,
  25. 25
    Tina Loayza, Lorna Schumann, Hepatitis C, Journal of the American Academy of Nurse Practitioners, 1999, 11, 9
  26. 26
    Michael Trauner, Peter Fickert, Rudolf E Stauber, Inflammation-induced cholestasis, Journal of Gastroenterology and Hepatology, 1999, 14, 10
  27. 27
    Jean-Pierre Zarski, Nouveaux traitements de l'hépatite C, Revue Française des Laboratoires, 1999, 1999, 312, 147

    CrossRef

  28. 28
    Aijaz Ahmed, Emmet B. Keeffe, OVERVIEW OF INTERFERON THERAPY FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 757

    CrossRef

  29. 29
    Trauner, Graziadei, Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases, Alimentary Pharmacology & Therapeutics, 1999, 13, 8
  30. 30
    G. Y. Minuk, The influence of host factors on the natural history of chronic hepatitis C viral infections, Journal of Viral Hepatitis, 1999, 6, 4
  31. 31
    Lili Kazemi-Shirazi, Christian Datz, Theresia Maier-Dobersberger, Klaus Kaserer, Franz Hackl, Claudia Polli, Petra E. Steindl, Edward Penner, Peter Ferenci, The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C, Gastroenterology, 1999, 116, 1, 127

    CrossRef

  32. 32
    C. Silvain, Traitements antiviraux de l’infection par le virus de l’hépatite C, La Revue de Médecine Interne, 1999, 20, 331s

    CrossRef

  33. 33
    Aijaz Ahmed, Emmet Keeffe, Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference, Journal of Gastroenterology and Hepatology, 1999, 14, 5s
  34. 34
    Melinda A. Beck, Orville A. Levander, DIETARY OXIDATIVE STRESS AND THE POTENTIATION OF VIRAL INFECTION1, Annual Review of Nutrition, 1998, 18, 1, 93

    CrossRef

  35. 35
    Paul C Adams, Iron overload in viral and alcoholic liver disease, Journal of Hepatology, 1998, 28, 19

    CrossRef

  36. 36
    Herbert L. Bonkovsky, Maureen Poh-Fitzpatrick, Neville Pimstone, Jorge Obando, Adrian Di Bisceglie, Christine Tattrie, Kristina Tortorelli, Paula LeClair, Mary G. Mercurio, Richard W. Lambrecht, Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america, Hepatology, 1998, 27, 6